Cipher Pharmaceuticals Inc
TSX:CPH

Watchlist Manager
Cipher Pharmaceuticals Inc Logo
Cipher Pharmaceuticals Inc
TSX:CPH
Watchlist
Price: 14.49 CAD 0.21% Market Closed
Market Cap: 367.6m CAD

Wall Street
Price Targets

CPH Price Targets Summary
Cipher Pharmaceuticals Inc

Wall Street analysts forecast CPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPH is 18.39 CAD with a low forecast of 14.65 CAD and a high forecast of 21 CAD.

Lowest
Price Target
14.65 CAD
1% Upside
Average
Price Target
18.39 CAD
27% Upside
Highest
Price Target
21 CAD
45% Upside
Cipher Pharmaceuticals Inc Competitors:
Price Targets
DHG
Dhg Pharmaceutical Joint-Stock Co
8% Upside
000423
Dong-E-E-Jiao Co Ltd
61% Upside
ABBOTINDIA
Abbott India Ltd
31% Upside
688185
CanSino Biologics Inc
5% Upside
VETO
Vetoquinol SA
20% Upside

Revenue
Forecast

Revenue Estimate
Cipher Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Cipher Pharmaceuticals Inc's revenue is 19%. The projected CAGR for the next 3 years is 28%.

19%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cipher Pharmaceuticals Inc

The compound annual growth rate of Cipher Pharmaceuticals Inc's operating income for the next 2 years is 68%.

N/A
Past Growth
68%
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Cipher Pharmaceuticals Inc

The compound annual growth rate of Cipher Pharmaceuticals Inc's net income for the next 3 years is 21%.

N/A
Past Growth
21%
Estimated Growth
Estimates Accuracy
11%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CPH's stock price target?
Price Target
18.39 CAD

According to Wall Street analysts, the average 1-year price target for CPH is 18.39 CAD with a low forecast of 14.65 CAD and a high forecast of 21 CAD.

What is Cipher Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
28%

For the last 13 years the compound annual growth rate for Cipher Pharmaceuticals Inc's revenue is 19%. The projected CAGR for the next 3 years is 28%.

What is Cipher Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
68%

The compound annual growth rate of Cipher Pharmaceuticals Inc's operating income for the next 2 years is 68%.

What is Cipher Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
21%

The compound annual growth rate of Cipher Pharmaceuticals Inc's net income for the next 3 years is 21%.

Back to Top